141 related articles for article (PubMed ID: 34158282)
1. Noncanonical Functions of C1s Complement Its Canonical Functions in Renal Cancer.
Magrini E; Garlanda C
Cancer Immunol Res; 2021 Aug; 9(8):855. PubMed ID: 34158282
[TBL] [Abstract][Full Text] [Related]
2. Complement C1s and C4d as Prognostic Biomarkers in Renal Cancer: Emergence of Noncanonical Functions of C1s.
Daugan MV; Revel M; Russick J; Dragon-Durey MA; Gaboriaud C; Robe-Rybkine T; Poillerat V; Grunenwald A; Lacroix G; Bougouin A; Meylan M; Verkarre V; Oudard SM; Mejean A; Vano YA; Perkins G; Validire P; Cathelineau X; Sanchez-Salas R; Damotte D; Fremeaux-Bacchi V; Cremer I; Sautès-Fridman C; Fridman WH; Roumenina LT
Cancer Immunol Res; 2021 Aug; 9(8):891-908. PubMed ID: 34039653
[TBL] [Abstract][Full Text] [Related]
3. Intracellular Factor H Drives Tumor Progression Independently of the Complement Cascade.
Daugan MV; Revel M; Thouenon R; Dragon-Durey MA; Robe-Rybkine T; Torset C; Merle NS; Noé R; Verkarre V; Oudard SM; Mejean A; Validire P; Cathelineau X; Sanchez-Salas R; Pickering MC; Cremer I; Mansuet-Lupo A; Alifano M; Sautès-Fridman C; Damotte D; Fridman WH; Roumenina LT
Cancer Immunol Res; 2021 Aug; 9(8):909-925. PubMed ID: 34039652
[TBL] [Abstract][Full Text] [Related]
4. Alternative complement pathway in hypocomplementemic/normal C1s-C1 inhibitor complex patients with SLE.
Levy RA; Qamar T; Lockshin MD
Clin Exp Rheumatol; 1990; 8(1):11-5. PubMed ID: 2347130
[TBL] [Abstract][Full Text] [Related]
5. Humoral complementomics - exploration of noninvasive complement biomarkers as predictors of renal cancer progression.
Revel M; Rezola Artero M; Hamidi H; Grunenwald A; Blasco L; Vano YA; Marie Oudard S; Sanchez-Salas R; Macek P; Rodriguez Sanchez L; Cathelineau X; Vedié B; Sautes-Fridman C; Herman Fridman W; Roumenina LT; Dragon-Durey MA
Oncoimmunology; 2024; 13(1):2328433. PubMed ID: 38487624
[TBL] [Abstract][Full Text] [Related]
6. Identification of a catalytic exosite for complement component C4 on the serine protease domain of C1s.
Duncan RC; Mohlin F; Taleski D; Coetzer TH; Huntington JA; Payne RJ; Blom AM; Pike RN; Wijeyewickrema LC
J Immunol; 2012 Sep; 189(5):2365-73. PubMed ID: 22855709
[TBL] [Abstract][Full Text] [Related]
7. Tumor Cells Hijack Macrophage-Produced Complement C1q to Promote Tumor Growth.
Roumenina LT; Daugan MV; Noé R; Petitprez F; Vano YA; Sanchez-Salas R; Becht E; Meilleroux J; Clec'h BL; Giraldo NA; Merle NS; Sun CM; Verkarre V; Validire P; Selves J; Lacroix L; Delfour O; Vandenberghe I; Thuilliez C; Keddani S; Sakhi IB; Barret E; Ferré P; Corvaïa N; Passioukov A; Chetaille E; Botto M; de Reynies A; Oudard SM; Mejean A; Cathelineau X; Sautès-Fridman C; Fridman WH
Cancer Immunol Res; 2019 Jul; 7(7):1091-1105. PubMed ID: 31164356
[TBL] [Abstract][Full Text] [Related]
8. Structural basis of the C1q/C1s interaction and its central role in assembly of the C1 complex of complement activation.
Venkatraman Girija U; Gingras AR; Marshall JE; Panchal R; Sheikh MA; Harper JA; Gál P; Schwaeble WJ; Mitchell DA; Moody PC; Wallis R
Proc Natl Acad Sci U S A; 2013 Aug; 110(34):13916-20. PubMed ID: 23922389
[TBL] [Abstract][Full Text] [Related]
9. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
Peitsch MC; Kovacsovics TJ; Tschopp J; Isliker H
J Immunol; 1987 Mar; 138(6):1871-6. PubMed ID: 3029223
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human complement subcomponent C1s lacking beta-hydroxyasparagine, sialic acid, and one of its two carbohydrate chains still reassembles with C1q and C1r to form a functional C1 complex.
Luo C; Thielens NM; Gagnon J; Gal P; Sarvari M; Tseng Y; Tosi M; Zavodszky P; Arlaud GJ; Schumaker VN
Biochemistry; 1992 May; 31(17):4254-62. PubMed ID: 1533159
[TBL] [Abstract][Full Text] [Related]
11. Uncoupling complement C1s activation from C1q binding in apoptotic cell phagocytosis and immunosuppressive capacity.
Colonna L; Parry GC; Panicker S; Elkon KB
Clin Immunol; 2016 Feb; 163():84-90. PubMed ID: 26769276
[TBL] [Abstract][Full Text] [Related]
12. Polyphosphate is a novel cofactor for regulation of complement by a serpin, C1 inhibitor.
Wijeyewickrema LC; Lameignere E; Hor L; Duncan RC; Shiba T; Travers RJ; Kapopara PR; Lei V; Smith SA; Kim H; Morrissey JH; Pike RN; Conway EM
Blood; 2016 Sep; 128(13):1766-76. PubMed ID: 27338096
[TBL] [Abstract][Full Text] [Related]
13. Antibody-mediates inhibition of human C1s and the classical complement pathway.
Carroll S; Georgiou G
Immunobiology; 2013 Aug; 218(8):1041-8. PubMed ID: 23434433
[TBL] [Abstract][Full Text] [Related]
14. Hypocomplementemia with low C1s-C1 inhibitor complex in systemic lupus erythematosus.
Lockshin MD; Qamar T; Redecha P; Harpel PC
Arthritis Rheum; 1986 Dec; 29(12):1467-72. PubMed ID: 3492208
[TBL] [Abstract][Full Text] [Related]
15. A molecular switch governs the interaction between the human complement protease C1s and its substrate, complement C4.
Perry AJ; Wijeyewickrema LC; Wilmann PG; Gunzburg MJ; D'Andrea L; Irving JA; Pang SS; Duncan RC; Wilce JA; Whisstock JC; Pike RN
J Biol Chem; 2013 May; 288(22):15821-9. PubMed ID: 23592783
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of immune complex-mediated activation of complement. Effects of agents modulating activation of, and the activated C1 complex.
Fletcher DS; Lin TY
Inflammation; 1980 Mar; 4(1):113-23. PubMed ID: 6967051
[TBL] [Abstract][Full Text] [Related]
17. Immune complex independent activation of complement, C1s secreted from hamster embryo malignant fibroblasts, Nil2C2 in serum free culture medium.
Yamaguchi K; Kato N; Sakai N; Matsumoto M; Nagasawa S; Hatsuse H; Toyoguchi T; Moriya H; Sakiyama H
Biochim Biophys Acta; 1994 Mar; 1205(1):133-8. PubMed ID: 8142477
[TBL] [Abstract][Full Text] [Related]
18. Non-coordinated biosynthesis of early complement components in a deficiency of complement proteins C1r and C1s.
Chevailler A; Drouet C; Ponard D; Alibeu C; Suraniti S; Carrère F; Renier G; Hurez D; Colomb MG
Scand J Immunol; 1994 Oct; 40(4):383-8. PubMed ID: 7939409
[TBL] [Abstract][Full Text] [Related]
19. Activation of C1 by soluble IgG aggregates as detected by a novel one-step hemolytic assay that specifically measures the proenzyme form of C1s.
Doekes G; van Es LA; Daha MR
J Immunol; 1983 Oct; 131(4):1924-9. PubMed ID: 6604753
[TBL] [Abstract][Full Text] [Related]
20. Complement component C5: engineering of a mutant that is specifically cleaved by the C4-specific C1s protease.
Ogata RT; Low PJ
J Immunol; 1995 Sep; 155(5):2642-51. PubMed ID: 7650393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
